REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Regulatory News (HAYD)

Share Price Information for Haydale (HAYD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.46
Bid: 0.45
Ask: 0.47
Change: 0.00 (0.00%)
Spread: 0.02 (4.444%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.46
HAYD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Share Options

26 Apr 2023 15:06

RNS Number : 5832X
Haydale Graphene Industries PLC
26 April 2023
 

 

For immediate release

26 April 2023

 

Haydale Graphene Industries plc

 

("Haydale", "the Company" or the "Group")

 

Grant of share options

 

 

Haydale (AIM: HAYD), the global advanced materials group, announces that on 25 April 2023 the Company approved the following:

 

1. under the 2020 EMI Scheme ("2020 EMI Scheme"), the grant of options to staff of the Group, over an aggregate 1,750,000 ordinary shares of 2p each in the capital of the Company ("Ordinary Shares"); and

2. under the Haydale Technologies, Inc ("HTI") Stock Appreciation Rights Plan 2020 ("2020 SAR"), the grant of stock appreciation rights ("Stock Appreciation Rights") to an employee of the Group's wholly owned US subsidiary, HTI, over an aggregate 1,000,000 Ordinary Shares.

(The 2020 EMI Scheme and the 2020 SAR , together the "Share Schemes". The new Options or Stock Appreciation Rights granted under the Share Schemes, together the "April 2023 Grants"). The April 2023 Grants represents approximately 0.35% of the Company's issued ordinary share capital.

 

Background to the April 2023 Grants

 

The Company adopted the Share Schemes to enable it to retain and incentivise staff and to reward them for the achievement of its longer-term objectives. The Share Schemes have certain performance criteria to ensure that value is created for shareholders before any value is delivered to Directors and key staff. The April 2023 Grants will extend the options to those that have joined since the previous grant of Options in November 2022. 

 

Terms of the April 2023 Grants

 

All of the April 2023 Grants have an exercise price of 2.25p per Ordinary Share (being a 42% premium to the closing mid-market price of the Company's Ordinary Shares on 25 April 2023, (the day of the approval of the April 2023 Grants) and can only be exercised between the third and tenth anniversary of the awards. The proportion of the awards made by the April 2023 Grants that are capable of vesting is dependent on certain performance criteria, directly linked to the performance of the Company's share price over the period to 30 September 2026 as follows:

 

% of April 2023 Grants subject to the Performance Condition

 

Performance Condition

 

30%

For a period of 15 consecutive dealing days, commencing after the date of the April 2023 Grants and ending on or before the 30 September 2024, the closing price of the Ordinary Shares exceeds 4p (four) per Ordinary Share.

 

30%

For a period of 15 consecutive dealing days, commencing after the date of the April 2023 Grants and ending on or before the 30 September 2025, the closing price of the Ordinary Shares exceeds 6p (six) per Ordinary Share.

 

40%

For a period of 15 consecutive dealing days, commencing after the date of the April 2023 Grants and ending on or before the 30 September 2026, the closing price of the Ordinary Shares exceeds 8p (eight) per Ordinary Share.

 

There are no other vesting criteria for the April 2023 Grants. If the share price does not reach the target price by their respective dates, that portion of the award will lapse.

 

The Company's Remuneration Committee retains the ability to amend the performance conditions for the April 2023 Grants and for future grants to ensure that such grants achieve the stated purpose.

 

Following the April 2023 Grants, the Company's total number of Options and SARs outstanding as at the date of this announcement is 101,775,000 representing approximately 12.95% of the Company's existing issued share capital and 9.90% on a fully diluted basis including all outstanding warrants.

 

The number of Ordinary Shares currently in issue is 785,852,475 and it is this number that has been used to calculate the above percentage shareholdings.

 

 

For further information:

Haydale Graphene Industries plc

David Banks, Non-Executive Chair

Tel: +44 (0) 1269 842 946

 

www.haydale.com 

finnCap (Nominated Adviser & Broker)

 

Julian Blunt/Edward Whiley, Corporate Finance

Andrew Burdis, ECM

Tel: +44 (0) 20 7220 0500 

 

 

Notes to Editors

 

Haydale is a global technologies and materials group that facilitates the integration of graphene and other nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness. Haydale has granted patents for its technologies in Europe, USA, Australia, Japan and China and operates from six sites in the UK, USA and the Far East.

 

For more information please visit: www.haydale.com

Twitter: @haydalegraphene

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKABKQBKDQQB
Date   Source Headline
22nd Feb 201911:00 amRNSPrice Monitoring Extension
22nd Feb 20197:01 amRNSProposed Placing and Open Offer
22nd Feb 20197:00 amRNSInterim Results
20th Feb 20192:06 pmRNSSecond Price Monitoring Extn
20th Feb 20192:00 pmRNSPrice Monitoring Extension
20th Feb 20199:00 amRNSPrice Monitoring Extension
20th Feb 20197:00 amRNSComment on Speculation
21st Jan 20197:00 amRNSHolding(s) in Company
15th Jan 20197:21 amRNSAgreement for Functionalised Piezoresistive Ink
14th Jan 20197:00 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSDirector/PDMR Shareholding
7th Jan 20194:15 pmRNSFurther re Issue of Equity
4th Jan 201911:51 amRNSDirector/PDMR Shareholding
28th Dec 20187:00 amRNSPDMR Shareholding
21st Dec 201812:22 pmRNSResult of AGM
21st Dec 20187:00 amRNSFinance facility, issue of equity, director change
30th Nov 20184:35 pmRNSPrice Monitoring Extension
29th Nov 20187:00 amRNSUpdate on functionalised graphene ink sales
29th Nov 20187:00 amRNSAnnual Report & Notice of AGM
27th Nov 20189:31 amRNSGEIC to join Haydale and Wheelsure collaboration
27th Nov 20189:05 amRNSSecond Price Monitoring Extn
27th Nov 20189:00 amRNSPrice Monitoring Extension
26th Nov 20184:40 pmRNSSecond Price Monitoring Extn
26th Nov 20184:35 pmRNSPrice Monitoring Extension
19th Nov 20187:00 amRNSLicense agreement for anti-counterfeiting product
13th Nov 20187:00 amRNSJoint Development Agreement with Star RFID
12th Nov 201812:40 pmEQSHardman & Co Research: Haydale (HAYD): Enlightenment delayed
9th Nov 20187:00 amRNSFinancing Update
12th Oct 20187:00 amRNSDevelopment funding from Niche Vehicle Network
28th Sep 20182:54 pmRNSDirector Dealing
27th Sep 20189:29 amRNSNOTIFICATION OF MAJOR HOLDINGS
26th Sep 20185:21 pmEQSHardman & Co Research: Haydale (HAYD): Exuberance, reality; enlightenment now to follow
18th Sep 20187:00 amRNSDevelopment Contract with the EIS
18th Sep 20187:00 amRNSFull Year Results
11th Sep 20187:00 amRNSContract Updates & Notice of Results
5th Sep 20187:00 amRNSBoard Changes
13th Aug 20187:00 amRNSDirector Dealing
8th Aug 20183:01 pmRNSNotification of Major Holdings
8th Aug 201811:00 amRNSPrice Monitoring Extension
7th Aug 201810:24 amRNSNOTIFICATION OF MAJOR HOLDINGS
1st Aug 20187:00 amRNSWorld's First Graphene Skinned Plane
18th Jul 20187:00 amRNSNPL & NGI launch graphene characterisation service
13th Jul 20182:05 pmRNSSecond Price Monitoring Extn
13th Jul 20182:00 pmRNSPrice Monitoring Extension
25th Jun 20187:00 amRNSPartnership with GEIC
22nd Jun 20184:20 pmRNSNotification of Major Holdings
20th Jun 20182:52 pmRNSDirector Dealing
19th Jun 20187:00 amRNSStrong Commercial Progress
18th Jun 20187:00 amRNSNotification of Major Holdings
13th Jun 20189:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.